Involvement of the IL23/Th17 Pathway in the Pathogenesis of Tunisian Pemphigus Foliaceus

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Features</td><td class="align_center">PF patients</td><td class="align_center">Controls</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Number</td><td class="align_center">115</td><td class="align_center">201</td></tr><tr><td class="align_left">Sex ratio</td><td class="align_center">1/14</td><td class="align_center">1/9</td></tr><tr><td class="align_left">Mean age</td><td class="align_center">35 (18–84)</td><td class="align_center">39 (14–73)</td></tr><tr><td class="align_left">Origin</td><td class="align_center" colspan="2">Center-southern regions of Tunisia</td></tr><tr><td class="align_left">Anti-Dsg1</td><td class="align_center">Positive</td><td class="align_center">Negative</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Characteristics of study populations.</div>

Mediators of Inflammation

tab1

Table 1

Table 1: Involvement of the IL23/Th17 Pathway in the Pathogenesis of Tunisian Pemphigus Foliaceus 